Sign inJoin waitlistJoin the waitlist

David Dickens

Division Director, Hematology-Oncology · Roy J. and Lucille A. Carver College of Medicine

Credentials: · · · · · ·

History

Hematology/Oncology Division · Nemours Children's Hospital, Florida
Present
Hematology/Oncology Division · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
Roy J. and Lucille A. Carver College of Medicine
Present

Pediatric Hematology Oncology
Cincinnati Children's Hospital Medical Center
1999–2002
Pediatrics
UPMC Children's Hospital of Pittsburgh
1996–1997
State University of New York Upstate Medical University
1992–1996

Research

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
Nature · 2023 · 458 citations
Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group
Journal of Clinical Oncology · 2012 · 273 citations
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
Journal of Clinical Oncology · 2025 · 213 citations

Smita Bhatia
13 papers · 3 as a resident
Julie Wolfson
9 papers
Michael Roth
9 papers
Allison Grimes
7 papers
David Freyer
7 papers
Jennifer Levine
7 papers
Wendy Landier
7 papers
AK
Alissa Kahn
6 papers
Archana Sharma
6 papers
AR
Arthur Ritchey
6 papers
Carla Schwalm
6 papers
Emily Johnston
6 papers

Clinical trials

Gemcitabine With Ascorbate Including Adolescents
Principal investigator · Withdrawn · Early phase 1
David Dickens
2023–2025
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
Site PI · Unknown · Phase 2
Jubilant DraxImage Inc.
2019–2025